NL7018031A - - Google Patents

Info

Publication number
NL7018031A
NL7018031A NL7018031A NL7018031A NL7018031A NL 7018031 A NL7018031 A NL 7018031A NL 7018031 A NL7018031 A NL 7018031A NL 7018031 A NL7018031 A NL 7018031A NL 7018031 A NL7018031 A NL 7018031A
Authority
NL
Netherlands
Application number
NL7018031A
Other versions
NL169583B (nl
NL169583C (nl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7018031A publication Critical patent/NL7018031A/xx
Publication of NL169583B publication Critical patent/NL169583B/xx
Application granted granted Critical
Publication of NL169583C publication Critical patent/NL169583C/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B33/00—Silicon; Compounds thereof
    • C01B33/113—Silicon oxides; Hydrates thereof
    • C01B33/12—Silica; Hydrates thereof, e.g. lepidoic silicic acid
    • C01B33/14—Colloidal silica, e.g. dispersions, gels, sols
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Dispersion Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Amplifiers (AREA)
NLAANVRAGE7018031,A 1969-12-12 1970-12-10 Werkwijze ter bereiding van een farmaceutisch preparaat met onder andere een perifere vaatverwijdende, jeukprikkelstillende en broncholytische werking, alsmede de aldus vervaardigde farmaceutische voorwerpen, en werkwijze ter bereiding van 1-(gesubstitueerd fenyl)-2-(arylalkylamino)-ethanol-derivaten. NL169583C (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1962497A DE1962497C3 (de) 1969-12-12 1969-12-12 Naphthylalkyl- a -hydroxyphenäthyl-amine, ihre Herstellung und diese enthaltende Arzneimittel

Publications (3)

Publication Number Publication Date
NL7018031A true NL7018031A (ru) 1971-06-15
NL169583B NL169583B (nl) 1982-03-01
NL169583C NL169583C (nl) 1982-08-02

Family

ID=5753745

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE7018031,A NL169583C (nl) 1969-12-12 1970-12-10 Werkwijze ter bereiding van een farmaceutisch preparaat met onder andere een perifere vaatverwijdende, jeukprikkelstillende en broncholytische werking, alsmede de aldus vervaardigde farmaceutische voorwerpen, en werkwijze ter bereiding van 1-(gesubstitueerd fenyl)-2-(arylalkylamino)-ethanol-derivaten.

Country Status (25)

Country Link
US (1) US3966814A (ru)
JP (3) JPS5116420B1 (ru)
KR (2) KR780000007B1 (ru)
AR (2) AR194205A1 (ru)
AT (3) AT317192B (ru)
BE (1) BE760252A (ru)
BG (1) BG17956A3 (ru)
CH (1) CH556322A (ru)
CS (3) CS151064B2 (ru)
DE (1) DE1962497C3 (ru)
DK (1) DK136526B (ru)
ES (3) ES386345A1 (ru)
FI (1) FI53301C (ru)
FR (1) FR2081347B1 (ru)
GB (1) GB1330188A (ru)
HU (1) HU162736B (ru)
IE (1) IE34807B1 (ru)
IL (1) IL35840A (ru)
NL (1) NL169583C (ru)
NO (1) NO131126C (ru)
PL (3) PL81424B1 (ru)
RO (3) RO61063A (ru)
SE (1) SE378101B (ru)
SU (2) SU417936A3 (ru)
YU (3) YU35753B (ru)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2187319B1 (ru) * 1972-06-09 1975-06-20 Bottu Exploit Labo
AU501137B2 (en) * 1975-12-11 1979-06-14 Tanabe Seiyaku Co., Ltd. Benzyl alcohol derivatives
JPS53149940A (en) * 1977-06-02 1978-12-27 Tanabe Seiyaku Co Ltd Novel benzyl alcohol derivatives and their preparation
US4849453A (en) * 1983-01-31 1989-07-18 Eli Lilly And Company Growth promotion
US5250546A (en) * 1984-09-28 1993-10-05 Nippon Chemiphar Co., Ltd. Amino-alcohol derivatives and processes for their preparation
DE3880628T2 (de) * 1987-11-13 1993-08-05 Glaxo Group Ltd Phenethanolamin-derivate.
US5194450A (en) * 1988-04-20 1993-03-16 Burroughs Wellcome Co. Anti-hypertensive sulfonanilides
GB8809314D0 (en) * 1988-04-20 1988-05-25 Wellcome Found Anti-hypertensive sulfonanilides
WO1999007666A1 (fr) * 1997-08-05 1999-02-18 Pola Chemical Industries Inc. Derives d'amine et leur procede de production
TW200605867A (en) 2004-03-17 2006-02-16 Novartis Ag Use of organic compounds
AU2013202127B2 (en) * 2006-08-10 2014-06-12 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Preparation of (R,R-)-fenoterol and (R,R)- or (R,S)-fenoterol analogues and their use in treating congestive heart failure
EP2064174B1 (en) 2006-08-10 2016-10-26 The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services Preparation of (r,r)- or (r,s)-fenoterol analogues and their use in treating congestive heart failure
JP5837890B2 (ja) 2010-03-10 2015-12-24 アメリカ合衆国 神経膠芽腫および星状細胞腫の治療におけるフェノテロールおよびフェノテロール類似体の使用
JP6208031B2 (ja) * 2014-01-30 2017-10-04 東芝ライフスタイル株式会社 ブラシレスモータおよびその製造方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE894396C (de) * 1944-05-21 1953-10-26 Troponwerke Dinklage & Co Verfahren zur Herstellung von 1-(o-, m- oder p-Oxyphenyl)-1-oxy-2-aralkylamino-aethanen
US3135797A (en) * 1958-04-15 1964-06-02 Colgate Palmolive Co Aromatic amino antispasmodic compounds
US3139441A (en) * 1960-02-16 1964-06-30 Colgate Palmolive Co Alpha (3, 4 dihidroxy phenyl)-beta-(nu-3, 14'-methylenedioxy-phenyl)-alkylamino ethanols
NL300751A (ru) * 1962-11-30 1900-01-01
GB1059968A (en) * 1964-01-20 1967-02-22 Ici Ltd Naphthalene derivatives
NL6401871A (ru) * 1964-02-27 1965-08-30
GB1095378A (ru) * 1965-06-22
DE1543372A1 (de) * 1966-10-18 1971-04-01 Boehringer Sohn Ingelheim Verfahren zur Herstellung von o-substituierten 3,4-Dioxyphenylalkanolaminen

Also Published As

Publication number Publication date
AT299924B (de) 1972-07-10
YU35868B (en) 1981-08-31
CH556322A (de) 1974-11-29
DK136526C (ru) 1978-03-28
AR198224A1 (es) 1974-06-07
JPS5138716B1 (ru) 1976-10-23
RO56808A (ru) 1975-03-15
KR780000007B1 (en) 1978-03-04
CS151064B2 (ru) 1973-09-17
FR2081347A1 (ru) 1971-12-03
YU137878A (en) 1981-02-28
YU35753B (en) 1981-06-30
YU301070A (en) 1980-12-31
RO61063A (fr) 1978-07-15
DE1962497B2 (de) 1979-01-25
DE1962497C3 (de) 1979-09-20
NL169583B (nl) 1982-03-01
BG17956A3 (ru) 1974-03-05
DE1962497A1 (de) 1971-06-16
JPS5116420B1 (ru) 1976-05-24
AT302284B (de) 1972-10-10
IE34807L (en) 1971-06-12
PL84354B1 (ru) 1976-03-31
GB1330188A (en) 1973-09-12
PL84355B1 (ru) 1976-03-31
YU137978A (en) 1981-02-28
NL169583C (nl) 1982-08-02
AR194205A1 (es) 1973-06-29
IE34807B1 (en) 1975-08-20
IL35840A (en) 1974-06-30
SU417936A3 (ru) 1974-02-28
PL81424B1 (ru) 1975-08-30
CS151062B2 (ru) 1973-09-17
JPS5221505B1 (ru) 1977-06-10
SU505349A3 (ru) 1976-02-28
CS151063B2 (ru) 1973-09-17
ES395482A1 (es) 1973-12-16
AT317192B (de) 1974-08-12
BE760252A (fr) 1971-06-11
NO131126C (ru) 1975-04-09
ES395481A1 (es) 1973-12-16
FI53301C (fi) 1978-04-10
SE378101B (ru) 1975-08-18
ES386345A1 (es) 1974-01-01
FI53301B (ru) 1977-12-30
DK136526B (da) 1977-10-24
HU162736B (ru) 1973-04-28
KR780000269B1 (en) 1978-07-24
FR2081347B1 (ru) 1974-08-30
NO131126B (ru) 1974-12-30
RO61132A (ru) 1976-12-15
YU35867B (en) 1981-08-31
SU384229A3 (ru) 1973-05-23
US3966814A (en) 1976-06-29
IL35840A0 (en) 1971-02-25

Similar Documents

Publication Publication Date Title
AU2270770A (ru)
FR2081347B1 (ru)
AU4221168A (ru)
JPS4835262B1 (ru)
AU2355770A (ru)
FR2059566B1 (ru)
AU5113869A (ru)
AT308690B (ru)
AU410358B2 (ru)
AU414607B2 (ru)
AU5109569A (ru)
AU5079269A (ru)
AR203167Q (ru)
AU4949169A (ru)
AU1036070A (ru)
CS148399B1 (ru)
AU5077469A (ru)
AU6261969A (ru)
AU5979569A (ru)
CH545650A (ru)
AU5066368A (ru)
BG18881A3 (ru)
BG20532A3 (ru)
BG17707A3 (ru)
CH559813B5 (ru)

Legal Events

Date Code Title Description
V1 Lapsed because of non-payment of the annual fee